NCT00505752: Investigation of a Long-Acting Follicle Stimulating Hormone in Infertile Women Undergoing Assisted Reproductive Technology (ART) |
|
|
| Completed | 2 | 520 | US | AS900672-Enriched 50 microgram (mcg), Hyperglycosylated r-hFSH, AS900672-Enriched 100 mcg, AS900672-Enriched 150 mcg, Follitropin alfa 150 international unit (IU), Gonal-f®, Follicle stimulating hormone (FSH), Recombinant human chorionic gonadotropin (r-hCG), Ovidrel®, Choriogonadotropin alfa | Merck KGaA, Darmstadt, Germany | Infertility | 09/08 | 09/08 | | |
NCT01079949 / 2006-005268-19: A Phase II Study to Assess the Efficacy and Safety of Luveris® (Lutropin Alfa) in Mid Follicular Phase for Controlled Ovarian Stimulation (COS) in Advanced Reproductive Age |
|
|
| Terminated | 2 | 93 | Europe | r-hLH + r-hFSH, Luveris®, Lutropin alfa, r-hFSH, Recombinant Human Choriogonadotropin (r-hCG), Ovitrelle®, GnRH antagonist, Cetrotide® | Merck KGaA, Darmstadt, Germany, Merck, S.L., Spain | Infertility, Ovulation Induction | 10/10 | 10/10 | | |
